You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radiographic progression

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (Avelumab, 2nd generation ADT (abiraterone or

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Avelumab
  • 2nd generation ADT (abiraterone or enzalutamide)
  • New Orleans, Louisiana
    Tulane University School of Medicine
Apr 6, 2022

Metastatic Triple Negative Breast Cancer Trial (Sabizabulin, Sacituzumab Govitecan-hziy, Sabizabulin/Sacituzumab govitecan-hziy

Withdrawn
  • Metastatic Triple Negative Breast Cancer
  • (no location specified)
Jan 24, 2022

Prostatic Tumors, Castration-Resistant Trial in Worldwide (Atezolizumab, Enzalutamide)

Active, not recruiting
Has Results
  • Prostatic Neoplasms, Castration-Resistant
  • Duarte, California
  • +157 more
Oct 26, 2022

Prostate Cancer, Prostate Carcinoma, Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Olaparib)

Recruiting
  • Prostate Cancer
  • +2 more
  • Guangzhou, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Feb 20, 2022

Prostate Cancer, Castration-resistant Prostate Cancer Trial in Washington, Baltimore (Olaparib, Vitamin C)

Not yet recruiting
  • Prostate Cancer
  • Castration-resistant Prostate Cancer
  • Washington, District of Columbia
  • +1 more
Aug 12, 2022

Metastatic Castrate Sensitive Prostate Cancer Trial in Worldwide (Niraparib, Abiraterone acetate (AA), Prednisone)

Recruiting
  • Metastatic Castrate Sensitive Prostate Cancer
  • Homewood, Alabama
  • +439 more
Jan 17, 2023

Carcinoma, Renal Cell Trial in Worldwide (Atezolizumab, Cabozantinib)

Active, not recruiting
  • Carcinoma, Renal Cell
  • Tucson, Arizona
  • +147 more
Jan 24, 2023

Bone-Metastatic, Castration-Resistant Prostate Cancer Trial in United States (KX2-391)

Completed
  • Bone-Metastatic, Castration-Resistant Prostate Cancer
  • Chicago, Illinois
  • +4 more
Feb 1, 2023

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 17, 2023

IPMN, IPMN, Pancreatic Trial in United States (Sulindac 400 MG, Placebo)

Recruiting
  • IPMN
  • IPMN, Pancreatic
  • Sulindac 400 MG
  • Placebo
  • Baltimore, Maryland
  • +3 more
Feb 16, 2022

Metastatic Hormone-sensitive Prostate Cancer Trial in United States (Darolutamide (BAY1841788, Nubeqa), ADT)

Recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Darolutamide (BAY1841788, Nubeqa)
  • ADT
  • Homewood, Alabama
  • +11 more
Jan 13, 2023

Prostate Cancer, Prostate Carcinoma, Metastatic Prostate Cancer Trial (Olaparib tablet, Abiraterone acetate, Prednisone tablet)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Olaparib tablet
  • +2 more
  • (no location specified)
Dec 7, 2021

Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))

Active, not recruiting
Has Results
  • Prostate Cancer
  • Homewood, Alabama
  • +228 more
Aug 2, 2022

Chronic Beryllium Disease to Pulmonary Sarcoidosis

Recruiting
  • Pulmonary Sarcoidosis
  • Chronic Beryllium Disease
    • Bobigny, Avicenne, France
      001 - Service Pneumologie
    Oct 27, 2023

    Brain Metastases, Radiation Necrosis, Recurrent Tumor Trial in Durham, Winston-Salem (Radiation Therapy, Steroid Therapy, Laser

    Recruiting
    • Brain Metastases
    • +3 more
    • Radiation Therapy
    • +2 more
    • Durham, North Carolina
    • +1 more
    Jun 23, 2022

    Castration Resistant Metastatic Prostate Cancer Trial in Baltimore (Testosterone cypionate, Enzalutamide, Testosterone

    Recruiting
    • Castration Resistant Metastatic Prostate Cancer
    • Testosterone cypionate
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University/Sidney Kimmel Cancer Center
    Aug 4, 2022

    Metastatic Hormone-Sensitive Prostate Cancer Trial in Worldwide (biological, drug, procedure, other)

    Active, not recruiting
    • Metastatic Hormone-Sensitive Prostate Cancer
    • Pembrolizumab
    • +3 more
    • Anchorage, Alaska
    • +212 more
    Aug 18, 2022

    Localized Prostate Cancer Participants Treated With Radical

    Not yet recruiting
    • High Risk Localized Prostate Cancer
      • Akita, Japan
        Akita University Hospital
      Aug 2, 2022

      Prostate Cancer Trial in Long Beach, West Los Angeles, Hines (stereotactic ablative radiotherapy, Pluvicto, topical

      Not yet recruiting
      • Prostate Cancer
      • stereotactic ablative radiotherapy
      • +2 more
      • Long Beach, California
      • +2 more
      Oct 13, 2023

      Prostatic Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Abiraterone acetate)

      Active, not recruiting
      • Prostatic Neoplasms
      • Pembrolizumab
      • +4 more
      • Fullerton, California
      • +192 more
      Oct 17, 2022

      Metastatic Prostate Cancer Trial in New York ([F-18] DCFPyL, PET/CT imaging)

      Active, not recruiting
      • Metastatic Prostate Cancer
      • [F-18] DCFPyL
      • PET/CT imaging
      • New York, New York
        Columbia University Irving Medical Center
      May 6, 2022

      Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

      Not yet recruiting
      • Renal Cancer
      • +3 more
      • Aurora, Colorado
        University of Colorado Cancer Center
      Jul 24, 2023

      Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)

      Completed
      Has Results
      • Prostate Cancer
      • San Francisco, California
      • +5 more
      Aug 9, 2022

      Prostatic Tumors Trial in Worldwide (Pembrolizumab, Docetaxel, Prednisone)

      Active, not recruiting
      • Prostatic Neoplasms
      • Pembrolizumab
      • +4 more
      • Mobile, Alabama
      • +214 more
      Nov 24, 2022

      Prostatic Tumors Trial in Worldwide (Pembrolizumab, Enzalutamide, Placebo)

      Active, not recruiting
      • Prostatic Neoplasms
      • Pembrolizumab
      • +2 more
      • Mobile, Alabama
      • +257 more
      Nov 22, 2022